Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RYAN S DIN

Allopathic & Osteopathic Physicians Internal Medicine Allergy & Immunology

NPI
1679139133
CMS profile
11419959
Location
BOSTON, MA

General Payments · PY2022–2024

$3,011.33

  • Reported across 38 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,211.33

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,030.84 33
Education $117.18 2
Travel and Lodging $63.31 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $1,000.00 1
PY2023 $800.00 1
PY2024 $1,211.33 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.09 09/23/2024 Food and Beverage Undisputed 01/23/2026 1103643834 CMS
ABBVIE INC. $121.98 10/09/2024 Food and Beverage Undisputed 01/23/2026 1103643836 CMS
ABBVIE INC. $32.36 10/11/2024 Food and Beverage Undisputed 01/23/2026 1103643838 CMS
ABBVIE INC. $30.57 10/24/2024 Food and Beverage Undisputed 01/23/2026 1103643840 CMS
ABBVIE INC. $27.84 11/25/2024 Food and Beverage Undisputed 01/23/2026 1103643842 CMS
AstraZeneca Pharmaceuticals LP $28.55 08/12/2024 Food and Beverage Undisputed 01/23/2026 1104335914 CMS
AstraZeneca Pharmaceuticals LP $27.60 08/28/2024 Food and Beverage Undisputed 01/23/2026 1105862450 CMS
AstraZeneca Pharmaceuticals LP $26.40 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105548315 CMS
AstraZeneca Pharmaceuticals LP $29.03 12/02/2024 Food and Beverage Undisputed 01/23/2026 1105473771 CMS
AstraZeneca Pharmaceuticals LP $22.52 12/02/2024 Education Undisputed 01/23/2026 1105505398 CMS
GENZYME CORPORATION $146.88 10/08/2024 Food and Beverage Undisputed 01/23/2026 1139784931 CMS
GENZYME CORPORATION $5.37 10/25/2024 Food and Beverage Undisputed 01/23/2026 1139784937 CMS
GlaxoSmithKline, LLC. $23.58 08/22/2024 Food and Beverage Undisputed 01/23/2026 1116434432 CMS
GlaxoSmithKline, LLC. $21.40 09/19/2024 Food and Beverage Undisputed 01/23/2026 1115966233 CMS
GlaxoSmithKline, LLC. $17.51 12/06/2024 Food and Beverage Undisputed 01/23/2026 1116564860 CMS
Grifols USA, LLC $63.31 08/16/2024 Travel and Lodging Undisputed 01/23/2026 1124718130 CMS
Grifols USA, LLC $63.35 08/16/2024 Food and Beverage Undisputed 01/23/2026 1124755258 CMS
Novartis Pharmaceuticals Corporation $21.77 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086960331 CMS
Novartis Pharmaceuticals Corporation $27.93 11/20/2024 Food and Beverage Undisputed 01/23/2026 1086960353 CMS
PFIZER INC. $36.95 10/01/2024 Food and Beverage Undisputed 01/23/2026 1131462598 CMS
PFIZER INC. $36.80 11/15/2024 Food and Beverage Undisputed 01/23/2026 1131462602 CMS
Regeneron Healthcare Solutions, Inc. $28.33 08/22/2024 Food and Beverage Undisputed 01/23/2026 1114038453 CMS
Regeneron Healthcare Solutions, Inc. $24.84 10/07/2024 Food and Beverage Undisputed 01/23/2026 1114038455 CMS
Regeneron Healthcare Solutions, Inc. $8.23 10/16/2024 Food and Beverage Undisputed 01/23/2026 1114038457 CMS
Regeneron Healthcare Solutions, Inc. $27.41 10/28/2024 Food and Beverage Undisputed 01/23/2026 1114038459 CMS
Regeneron Healthcare Solutions, Inc. $7.16 10/30/2024 Food and Beverage Undisputed 01/23/2026 1114038461 CMS
Regeneron Healthcare Solutions, Inc. $9.93 11/06/2024 Food and Beverage Undisputed 01/23/2026 1114038463 CMS
Regeneron Healthcare Solutions, Inc. $94.66 11/06/2024 Education Undisputed 01/23/2026 1114038466 CMS
Regeneron Healthcare Solutions, Inc. $9.99 11/13/2024 Food and Beverage Undisputed 01/23/2026 1114038468 CMS
Regeneron Healthcare Solutions, Inc. $26.71 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114038470 CMS
Regeneron Healthcare Solutions, Inc. $6.47 11/20/2024 Food and Beverage Undisputed 01/23/2026 1114038472 CMS
Regeneron Healthcare Solutions, Inc. $28.40 12/05/2024 Food and Beverage Undisputed 01/23/2026 1114038474 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $25.93 12/31/2024 Food and Beverage Undisputed 01/23/2026 1153575138 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.96 08/27/2024 Food and Beverage Undisputed 01/23/2026 1137531814 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.26 09/04/2024 Food and Beverage Undisputed 01/23/2026 1137531818 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.26 11/18/2024 Food and Beverage Undisputed 01/23/2026 1137531821 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.